Selection for cisplatin resistance in the A2780 ovarian cancer cell line led to decreased DNA hypermethylation around the CDCP1 gene [39], while DNA methylation near the CDCP1 gene promoter region negatively correlates with CDCP1 protein levels in breast cancer [40]. The gene discussed is CDCP1; the disease is breast carcinoma.